Previous 10 | Next 10 |
2024-04-09 11:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. We are seeing underlyi...
2024-04-02 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-01 08:53:49 ET More on the markets My Current View Of The Market: April 2024 Edition (Technical Analysis) SPY: Potential, Yes, But Risks Ahead Too Where This Market Is Going (Technical Analysis) Investors are sellers of fund assets for the second cons...
2024-04-01 07:30:05 ET Wells Fargo analyst issues OVERWEIGHT recommendation for INSM on April 1, 2024 05:51AM ET. The previous analyst recommendation was Overweight. INSM was trading at $27.13 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-04-01 07:00:05 ET Tiago Fauth from Wells Fargo issued a price target of $55.00 for INSM on 2024-04-01 05:51:00. The adjusted price target was set to $55.00. At the time of the announcement, INSM was trading at $27.13. The overall price target consensus is at $56.00 ...
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference PR Newswire — Additional Data from ARISE Study Evaluating the Impact of ARIKAYCE on Microbiologic Outcomes in Patients with Newly Diagnosed or...
Insmed To Present at Three March Conferences PR Newswire BRIDGEWATER, N.J. , Feb. 29, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today ...
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health PR Newswire — New survey reveals the prevalence of "Unseenism," which can be described as a social phenomenon where gender and age biases can leav...
2024-02-22 13:00:04 ET Insmed Incorporated (INSM) Q4 2023 Earnings Conference Call February 22, 2024 8:30 AM ET Company Participants Bryan Dunn – Head-Investor Relations Will Lewis – Chairman and Chief Executive Officer Sara Bonstein – Chief ...
2024-02-21 12:12:01 ET More on Insmed JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower Seeking Alpha’s Quant Rating on Insmed Historical earnings data for Insmed Financial information for Insmed Read the full article ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 10:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-09 08:00:06 ET Vamil Divan from Guggenheim issued a price target of $95.00 for INSM on 2024-07-09 06:44:00. The adjusted price target was set to $95.00. At the time of the announcement, INSM was trading at $70.05. The overall price target consensus is at $72.91 w...
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference PR Newswire —New Graph Depicting 52-Week FEV1 Data Illustrate Significantly Less Decline in Lung Function for Bren...